him any protection? with two shots? >> yeah, so, this is the question. correct. so, we know the fact that the fda itself kind of pushed and nudged pfizer to put in the application, it just tells me, knowing how the fda works, they're very conservative. they didn't compromise kind of what they're doing, but there must have been incredible clinical data. remember, in the trial was about 1,700 children in that 6-month to 4-year age group, so we know that there were children in the control group that went through omicron. of course, these children, what they did, they compared their antibody levels to older children or to adolescents and young adults, and the safety profile was there, but that initial data in december said that it wasn't the same level of antibodies that they would have expected, but that's just in the lab, and then we have the real-world of an omicron surge and we had thousands of children in that trial who were tested with these clinical diseases,